Crossmark

Could 68-Ga PSMA PET/CT become a new tool in the decision-making strategy of prostate cancer patients with biochemical recurrence of PSA after radical prostatectomy? A preliminary, monocentric series

Crossref DOI link: https://doi.org/10.1007/s11547-018-0890-7

Published Online: 2018-04-23

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

De Bari, Berardino

Mazzola, Rosario

Aiello, Dario

Fersino, Sergio

Gregucci, Fabiana

Alongi, Pierpaolo

Nicodemo, Maurizio

Cavalleri, Stefano

Salgarello, Matteo

Alongi, Filippo
License Information

Text and Data Mining valid from 2018-04-23
More Information

Article History

Received: 20 October 2017

Accepted: 9 April 2018

First Online: 23 April 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All procedures were in accordance with the ethical standards and the Helsinki declaration. All the patients gave their informed consent prior to inclusion in the study.

Document is current

Any future updates will be listed below